Etoricoxib in the treatment of primary dysmenorrhea in Chinese patients: a randomized controlled trial.

@article{Yu2014EtoricoxibIT,
  title={Etoricoxib in the treatment of primary dysmenorrhea in Chinese patients: a randomized controlled trial.},
  author={Qi Yu and Xiaqin Zhu and Xiaowei Zhang and Yi Zhang and Xiaomao Li and Qi Hua and Qing Chang and Qindi Zou and Wen Di and Yuanqing Yao and Wenbo Yu and Ji Liu and Anish Mehta and Li Yan},
  journal={Current medical research and opinion},
  year={2014},
  volume={30 9},
  pages={
          1863-70
        }
}
OBJECTIVE Assess the efficacy and safety of etoricoxib 120 mg compared with ibuprofen 600 mg qid in the treatment of moderate to severe primary dysmenorrhea in Chinese women. METHODS This multicenter, double-blind, two-period, cross-over study randomized healthy, Chinese women ≥18 years of age to etoricoxib 120 mg qd or ibuprofen up to 2400 mg (600 mg qid) upon onset of moderate or severe primary dysmenorrhea symptoms during two menstrual cycles. The primary efficacy endpoint was Total Pain… CONTINUE READING
1
Twitter Mention